ORG Partners LLC Boosts Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

ORG Partners LLC grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 14.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,139 shares of the healthcare conglomerate’s stock after buying an additional 273 shares during the period. ORG Partners LLC’s holdings in UnitedHealth Group were worth $1,086,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. VitalStone Financial LLC boosted its position in shares of UnitedHealth Group by 600.0% during the 2nd quarter. VitalStone Financial LLC now owns 70 shares of the healthcare conglomerate’s stock valued at $36,000 after acquiring an additional 60 shares during the last quarter. Linscomb Wealth Inc. increased its holdings in shares of UnitedHealth Group by 11.1% in the 2nd quarter. Linscomb Wealth Inc. now owns 1,054 shares of the healthcare conglomerate’s stock worth $537,000 after buying an additional 105 shares during the last quarter. Qsemble Capital Management LP lifted its holdings in shares of UnitedHealth Group by 161.3% during the 2nd quarter. Qsemble Capital Management LP now owns 8,414 shares of the healthcare conglomerate’s stock worth $4,285,000 after acquiring an additional 5,194 shares during the last quarter. Johnson Investment Counsel Inc. raised its position in UnitedHealth Group by 0.5% during the second quarter. Johnson Investment Counsel Inc. now owns 268,033 shares of the healthcare conglomerate’s stock valued at $136,499,000 after purchasing an additional 1,363 shares in the last quarter. Finally, BOKF NA increased its position in shares of UnitedHealth Group by 2.9% during the 2nd quarter. BOKF NA now owns 66,217 shares of the healthcare conglomerate’s stock valued at $33,722,000 after purchasing an additional 1,857 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UNH traded up $3.48 during mid-day trading on Friday, reaching $528.00. The stock had a trading volume of 1,571,818 shares, compared to its average volume of 3,514,637. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The business has a fifty day moving average of $556.20 and a 200 day moving average of $561.20. The firm has a market cap of $485.91 billion, a price-to-earnings ratio of 34.40, a PEG ratio of 1.53 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. During the same quarter in the prior year, the company posted $6.56 earnings per share. The business’s quarterly revenue was up 9.2% compared to the same quarter last year. Equities analysts predict that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were issued a $2.10 dividend. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.59%. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on UNH shares. TD Cowen boosted their price objective on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a report on Friday, October 18th. Oppenheimer raised their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Truist Financial reduced their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research report on Monday. Royal Bank of Canada dropped their price objective on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research note on Wednesday, October 16th. Finally, Stephens upped their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a report on Thursday, December 5th. Two equities research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $626.79.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.